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Background: Adherence to CF treatments is poor, which can lead to negative health outcomes. The objective of our study was to qualitatively
investigate the barriers and facilitators of self-management among older adolescents and adults with CF.
Methods: Individual semi-structured interviews were conducted, audio-taped, transcribed verbatim and coded to identify common themes.
Results:Twenty-five patientswere interviewed. Four broad themeswere identified:Barriers to Self-Management (e.g., treatment burden (identified by 64%
of patients), accidental or purposeful forgetting (60%), no perceived benefit (56%)), Facilitators of Self-Management (e.g., CF clinic visits (76%), social
support (68%), perceived benefit (68%)), Substitution of Alternative Approaches to ConventionalManagement (36%) andPlanned Non-adherence (32%).
Conclusions: Older adolescents and adults with CF identified many barriers and facilitators of adherence that may be amenable to self-
management counseling strategies, particularly the use of health feedback.
© 2010 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved.Keywords: Self-management; Adherence; Quality of life; Feedback1. Introduction
In recent years, the lifespan for people with cystic fibrosis
(CF) has markedly improved. Nearly half of all people with CF
in the U.S. are now adults [1]. Extended life expectancy is due, in
part, to the performance of a complex and time-consuming home
program of self-care. The foundations of this treatment plan are
oral and inhaled antibiotic therapy, inhaled mycolytic therapy,
airway clearance, pancreatic enzymes and nutritional support
including vitamins and supplements [2]. A growing number of⁎ Corresponding author. Johns Hopkins Adherence Research Center, The
Johns Hopkins University, 5501 Hopkins Bayview Circle, 4B.74, Baltimore,
MD 21224, United States. Tel.: +1 410 550 7755; fax: +1 410 550 2612.
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doi:10.1016/j.jcf.2010.08.016older adolescents and adults with CF also have CF-related
diabetes, necessitating insulin injections and blood glucose
monitoring [1].
For these treatments to be fully effective, CF patients must
adhere to a variety of health behaviors, and to the dosage, order,
and frequency of medication and other treatments recom-
mended by their CF care team. Objective medication adherence
estimates for this population are low, ranging from 31 to 79%
regardless of the type of drug (antibiotic, mucolytic, and
pancreatic enzyme) [3–10]. A recent study based on food
diaries collected at a CF clinic visit found that only 72% of
patients met overall calorie recommendations and no patient
achieved the recommended intake of fat [11]. Self-reported
adherence to airway clearance is also poor, ranging between 41
and 54% [12–14]. Adherence decreases as children transition to
adolescence and may remain low through emerging adulthoodd by Elsevier B.V. All rights reserved.
Table 1
Participant characteristics (N=25).
Demographic variable N %
Sex Female 12 48
Male 13 52
Age (years) 16–19 9 36
20–29 10 40
30–35 6 24
Race African American 2 8
Caucasian 23 92
Marital status With a partner 1 4
Married 2 8
Divorced 4 16
Single/never married 18 72
Education Some high school or less 9 36
High school diploma/GED 2 8
Vocational school 1 4
Some college 1 4
College degree 8 32
Professional or graduate degree 4 16
Current work/school status Not attending work/school
for health reasons
3 12
Attending school outside of home 9 36
Working full/part time 13 52
FEV1 Percent Predicted Mild (N71%) 13 52
Moderate (40–70%) 11 44
Severe (b39%) 1 4
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health outcomes including an increased number of pulmonary
exacerbations and baseline lung function [9].
Adherence to CF treatments involves a variety of complex
behaviors and is time consuming as well, placing a significant
treatment burden on the patients. Several studies have examined
barriers to self-management in CF, but only in pediatric
populations [16–19]. It is unclear if the barriers faced by children
with CF are the same for older adolescents and adults. A better
understanding of both barriers and facilitators of treatment
adherence may be valuable for developing effective strategies to
promote adherence. The objective of our study was to qualitatively
explore the perceptions of barriers and facilitators of treatment
adherence experienced by older adolescents and adults with CF.
2. Methods
2.1. Design
Individual semi-structured interviews were conducted with
adolescent and adult CF patients to identify perceptions of
facilitators and barriers to medication adherence. We conducted
individual interviews rather than relying on focus groups because
of the potential for cross-infection. Individuals were eligible for
participation if they were 16 years of age or older and had a
confirmed diagnosis of CF, were scheduled for an upcoming
clinic visit, were clinically stable (e.g., not on intravenous
antibiotics for the previous 14 days), and had been prescribed
inhaled mucolytic, inhaled antibiotic therapy, chronic macrolide
therapy and/or hypertonic saline therapy for the last 12 months.
2.2. Sample
We attempted to contact 68 people for an interview who were
identified from a review of the pediatric and adult CF clinic
schedule. Of the 42 people we reached by phone, 29 agreed to
participate; the primary reasons for refusal were work or school
conflicts, busy schedules, and lack of interest. Twenty-nine
individuals agreed to participate; however, two failed to show for
their clinic appointments, one could not be scheduled and one
participant was interviewed but later deemed ineligible for the
study. Twenty-five participants were interviewed and their
transcripts were qualitatively analyzed. Interviews were con-
ducted between March and December 2008. Informed consent
was obtained prior to the interview and participants received
$50.00 and a parking coupon. The Johns Hopkins University
Institutional Review Board (IRB) approved this project.
2.3. Procedures
This study used a naturalist inquiry approach [20]. Thus, we
had a priori research questions (e.g., what are the barriers to
adherence?) but did not test any specific hypotheses which we
believed would be premature given the scarcity of research in this
area. All interviews were conducted by one of the authors (MZ).
Themean time for interviewswas 45 min (range 23–71 min), and
each interview was audio-taped and transcribed verbatim. Afterevery five interviews the transcripts were independently reviewed
by the investigators for common themes, with group consensus
determining which themes warranted further investigation. We
explored these themes with subsequent participants and retained
only those themes that were uniformly endorsed, a method of
“member checking” or respondent validation [20]. This iterative
process is common to qualitative research [21] and assures that
relevant data is retained as the critically important final codes.
After 20 interviews, no new themes were elicited; we interviewed
an additional 5 subjects to confirm that data saturation had been
achieved. Coding of common themes involved multiple steps:
group consensus identified and defined initial codes, three
reviewers independently coded each transcript with discrepancies
resolved through discussion, and the investigators provided a final
review of themes to ensure clarity and comprehensiveness of
definitions and final thematic names [22].
3. Results
Fifty-two percent of participants were male and 92% were
Caucasian with a mean age of 24 years (SD=6.7 years;
range=16–35) and a mean FEV1% predicted of 68.4%
(SD=24.7; range=25.2%–118.2%). Seventy-two percent of
subjects were not married, 64% had a high school degree or
higher education and 52% had full-time or part-time employ-
ment. Table 1 shows additional characteristics of the sample.
3.1. Qualitative themes
Four broad themes emerged from the analysis of the
transcripts: barriers to CF self-management, facilitators of CF
Table 2
Additional exemplars characterizing the theme Barriers to CF self-management.
Code Definition Exemplar Quotes Frequency of
response n (%)
Treatment burden The length, frequency, and complexity
of treatments affects adherence
• “The process involved, the time it takes; the reality it makes
you face. The more I have to do, the more I don't do it.”
16 (64)
• “My time is more valuable to me than that. It's not worth it for me.”
Social demands Balancing the need to do time-intensive
treatments in the face of social demands
• “A friend called me ‘Hey, I have tickets to a baseball game.
You want to go?’ I am like, ‘Well, can I plan my treatment around it?’”
15 (60)
• “If I want to stay the night at a friend's, I have to do all this crap first.”
• “I know that a lot of time when I am sitting there watching
TV or playing on the computer I could be doing it (treatment).
But I just don't because it is more fun not to.”
Work demands Balancing the burden of work
and treatments
• “I put my career ahead…sometimes I'll think about work before
I take my medicine.”
15 (60)
• “I work full-time and I work probably 50 hours a week right
now so wanting to have a ‘normal’ life, where you go out to get
drinks with friends, go to spend time with friends, or go for a
bike ride, or a run or do something to try to maintain a normal
life. The most difficult part is fitting the treatments into that.”
• “If it's a choice between going away for work and taking my
machine or taking meds that I think might get in the way, I'm
probably going to choose work.”
Forgetting Purposeful or inadvertent forgetting • “Just remembering the enzymes is hard. If I got paid–even
if I had like $5.00–to remember my enzymes.”
15 (60)
• “A lot of times, laziness or life just gets in the way.”
• “It's just a matter of forgetting.”
Absence of perceived
health benefit
The presence or absence of symptoms,
or the failure to experience benefits or
consequences from treatment could
result in non-adherence
• “If I feel like it is doing something, then I will take my
medicines. If I feel like I am just taking medicine because my
doctors are befuddled…then I don't take it.”
14 (56)
• “If that was an inhaled treatment sitting there for 15 minutes
to a half hour and it's not doing anything? I would be very
unmotivated to do it, especially if I did not see any effect at all.”
Fatigue Fatigue caused treatments to be omitted • “After a long day at work, a lot of times, I just want to kick
back and just, like, go to sleep.”
14 (56)
• “If I am out Friday and don't get home until 12 or 1, I go
to bed. That (treatment) is the last thing I want, or feel like, or
will remember to do. I'm tired…just literally coming home and
not washing my face, not brushing my teeth. So if I'm not doing
those things, I'm certainly not going to take the time to set up my
breathing medication…that would go out the window after you
have been drinking a bit.”
• “To just come home and crash just like everybody else…there
have been nights where I had to turn down doing my treatment
because I couldn't do it earlier.”
Stigma/embarrassment Stigma and embarrassment related to
performing treatments in public
• “When I was married I wouldn't do my breathing treatments
around my wife…like my nebulizer, after I use it, I push it under
my bed. I guess maybe I am hiding it…It is more my concern how
they are going to react seeing their sick friend, sick husband,
sick boyfriend.”
9 (36)
• “I have 2 roommates…I wasn't going to do it in front of him.
I did it while they were off at work. I do that in my room.”
• “When I am out with friends, I don't carry them (enzymes)
like my parents tell me to do because I would feel embarrassed.”
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conventional management and planned non-adherence.
3.1.1. Barriers to CF self-management (Table 2)
Table 2 reflects 8 common impediments to CF self-
management reported by 24 (96%) subjects. Thus a barrier is
anything identified by the subjects as decreasing the likelihood that
they will follow a prescribed treatment regimen. The most
frequently noted barrier, mentioned by 16 (64%) subjects, is
captured by the code Treatment Burden which reflects the length,frequency, and complexity of treatments. One subject noted that
“I'm not on as much as I have been before, in part because I am
doing well but also because my doctors realized that I don't do it
because therewas thatmuch to do…They know thatwe have lives.”
The next two codes— SocialDemands andWorkDemands—
highlight the tension between the commitment to perform
lengthy CF care and the desire to participate in competing social
events or meet professional responsibilities. Fifteen subjects
(60%) identified either or both of these barriers: “I want to do it
so I can stay healthy and stuff but I also want to go out and hang
428 M. George et al. / Journal of Cystic Fibrosis 9 (2010) 425–432out,” and “Doing nebulizers and stuff—that is not normal for
most people. They can just go home or go outside or do
homework. And you see people outside and you are like ‘I don't
want to be in here doing this stuff. I want to go outside’…
occasionally I will skip them and do something that is more
fun.” Another said “Holding down a full-time job and living life
normally— time is a big thing…I would rather do all the things
I want to do instead of sit home and do all the things I should
and miss out on a bunch of stuff… I am quality over quantity.”
Fifteen subjects (60%) identified accidental or purposeful
forgetting as another CF self-management obstacle, exemplified
by the code Forgetting. One subject commented that “During
the weekdays I have a set schedule when I go to bed but on the
weekend, it is like ‘I'm going to do this later.’ And then I won't
do it later and I will just kind of forget…I don't remember
because I am kind of happier when I am not thinking about it.”
The next code,Absence of PerceivedHealth Benefits, described
14 subjects' (56%) treatment decisions. For some the absence of
symptoms or the lack of negative sequelae for skipped treatments
promoted non-adherence. Exemplars include “It is the chicken and
the egg sort of thing. If you are not feeling sick then you don't feel
the need to do the medication” and “I have not taken my meds
before and it's not like my PFTs [pulmonary function tests] have
dropped significantly or anything has grown.” For others, the
failure to achieve symptom relief prompted non-adherence.
“There've been times where I said ‘I am going to stick with this’
and for 3 or 4 months I did exactly what they said as far as the
nebulizers, the TOBI…and to be honest, I didn't feel any different
at all… I just don't feel like it because I don't see any benefits.” Still
others anticipated the presence of symptoms would facilitate
treatment adherence, commenting, “If I started to feel worse, and it
did start to affect my everyday life, I would definitely do it more.”
The code Fatigue captures the experience of fourteen (56%)
participants, describing how fatigue made CF self-management
more onerous. Not surprisingly, this was most often associated
with early morning and late evening routines. “When I go to bed
I am really tired, and I don't want to take the extra time to do it,”
said one subject. Three (12%) adults specifically identified the
combination of alcohol ingestion and fatigue as a problem on
weekends; comments included “Friday is usually the problem; it
is just because of my lifestyle. And I don't feel like doing it.
Quite honestly, when I'm drunk, I am not thinking, ‘Hey, time
to do some TOBI.’ So I do it Saturday morning.”
The final code in the theme barriers to CF self-management
was Stigma/Embarrassment. This code was identified by 9
individuals (36%) and specifically reflected the stigma of
performing treatments in front of others, regardless of whether
they were familiar or not. One subject said, “The last girl I was
dating for a few months, I stayed at her house probably like half
the time, so you know, all that time I wasn't doing any of it
because I wouldn't do it in front of somebody I don't know. I just
get embarrassed. I don't know why. I was married for 3½ years,
and the entire time, I wouldn't do anything in front of her.”
3.1.2. Facilitators of CF self-management (Table 3)
The second theme, was also widely endorsed (n=24; 96%);
and represents the patients' perception of things that increasethe likelihood that they will follow a prescribed treatment
regimen (Table 3). We identified seven facilitator codes. CF
Clinic, the first code, illustrates how attending CF clinic,
receiving feedback on PFT results, and interacting with the CF
team promoted self-management. This code was reported by 19
(76%) subjects. One subject said, “After I have my appoint-
ments and I come home, I am really amped up and I am like
‘OK. I can do this’. Then sometimes right before my
appointments, I am like, ‘Oh crap! I am going to see the
doctor!’ and I do everything.” Another offered, “When I come
in here and I have my PFTs done and I see my numbers aren't
where we would like them…then I feel bad about it and I get on
it real good for a period of time…If you are here every 3 months,
then it is almost the psychological whip to keep you on task.”
Regarding her CF doctor, one participant said, “[He] was really
funny and outgoing and really nice and that helped a lot getting
me back into clinic. Because I don't come as often as I should,
but I come a lot more than I used to.”
The next two codes Support & Reminders and Presence of
Perceived Health Benefits were each reported by 17 (68%)
subjects. Support & Reminders reflected the role of significant
others, reminders, and monitoring devices in improving
adherence to CF self-management. Quotes included, “He'll
[boyfriend] make me [do treatments]… I do it more often when
he's around…He will set it up for me.” and “The Vest had a
counter on it; how many minutes I did it. The company…would
call periodically and I had to read them the numbers to see if I
was using it. That only lasted a few months and then it was like,
ok, no one is checking up anymore. I lost accountability.”
Presence of Perceived Health Benefits reflects subjects'
observation that CF self-management improved symptoms
and maintained health. This code also captured how the
presence of symptoms motivated subjects to perform self-
management. Participants expressed these views in the
following statements: “The nebulizers—you can really feel
them affecting you. So it's more you are like, ‘This is really
working for me’” and “[If I don't do treatments] I'll notice the
next day–immediately–how awful I feel…The more strict
regimen you keep yourself on, the better you feel.”
The fourth code, Ease of Completion, reflected the degree of
effort the treatment required for 12 (48%) subjects. One
participant noted that it “needs to be less complicated and less
time consuming. The easier, the shorter, and the quicker it is, the
more likely I am to do it…things like popping pills, taking a
quick puff of an inhaler—easy! I can do that. But it's the things
that take prep work and take actual time to do them that I just
don't do.”
Perhaps surprisingly, having a routine was only identified by
12 (48%) subjects as a facilitator of CF self-management.Habit/
Routine described the difficulty subjects had in maintaining
self-management practices over the weekend, saying “Pills I
don't have an issue with because…I do it out of habit. Weekends
are the worst for me because I am not on a routine in the
morning.”
Distractions & Rewards was the code that highlighted how
distractions or rewards were used to facilitate CF self-
management by 11 (44%) subjects. “You know Facebook? I
Table 3
Additional exemplars characterizing the theme Facilitators of CF self-management.
Code Definition Exemplar quotes Frequency of
response n (%)
CF clinic Attending CF clinic promoted
CF self-management
• “If it is coming close to an appointment here I might get nervous, like
‘Well, if I don't do it, my lung functions might be down more.’ So that
may make me do it more.”
19 (76)
• “I have fallen off the bandwagon like a month after I was at clinic last
but I snapped back into it and started back on the bandwagon and doing
things right before my [next] visit…I jumped back on to look OK to the
doctors… because I was running around and doing a lot of partying and I
didn't want them to know what I was doing so I jumped back on and got
into the swing of things maybe 2 or 3 days before my visit to make myself
a little above where I was the last time and it would work.”
• “If I go to the doctor and my PFTS are lower than usual…it does make
it more likely to take my medicine and be on a tighter regimen.”
Support & reminders Significant others and reminders
encouraged adherence
• “My mom carries enzymes in her purse so I have them.” 17 (68)
• “We actually bought…a small hand held thing (FEV1 meter) that you
blow into…so you sort of know how you're tracking…that is definitely a
good thing to have.”
• “My mom nags me to do it so it is not really like I have a choice.”
• “I have a little calendar in the drawer that I keep everything, and I




symptoms and maintained health;
symptoms motivated individuals
to adhere
• “I can tell the difference when I do my Vest and when I don't…When
I don't do my enzymes, I can definitely tell the difference. My stomach hurts.”
17 (68)
• “I can be as close to normal as possible by taking these medications.”
• “The nebulizer is so helpful in keeping you healthy to the utmost…
Whenever you cough the stuff out of your lungs, I always say ‘That is
5 min more on my life.’ It is a good feeling.”
Ease of completion A low degree of effort required
to do treatment enhanced adherence
• “I would probably do the Pulmozyme and the Acapella because they are
both quick…just those two [and] the enzymes are not that big of a deal-
because it is just throwing then down the throat.”
12 (48)
• “Taking pills is fine. I am good at that because it is just a split second thing.”
Habit/ routine Having a routine helped
facilitate CF self-management
• “It is a lot easier to do it during the week because I have a routine. I am
not out. I am home. Weekends are unpredictable.”
12 (48)
• “I'm one of those people who follows the schedule to an ‘anal T.’ Honestly,
my life is scheduled to the second so I usually have exact times when I
take my things daily…nothing really throws me off…Monday–Wednesday–




were methods used to
promote adherence
• “I would do my homework while I was doing nebs and stuff, so that was
something I didn't particularly enjoy anyways so then I would be done with
my medicine and done with my homework and then I could do whatever
I wanted to do after that.”
11 (44)
• “I do my Vest in front of the computer. It is on (Vest) so I am on the
computer doing other stuff and I normally don't think about it.”
Guilt Feelings of guilt about
non-adherence promoted
adherence
• “I feel bad about it…I am not the sort of person who doesn't do the treatments.” 11 (44)
• “I kind of feel a little bit guilty, like I am supposed to do this and I didn't,
you know? I did it yesterday, why couldn't I do it today?...So the next day
I make sure I do it. It works to give me a little slap in the face to do your
stuff even when you don't want to.”
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until after I had done my therapies for the day,” said one subject.
Guilt was the code that described how guilt was a motivating
force for eleven (44%) participants. “When I'm doing it right
(taking treatments) I feel a little better just because I am doing
what they tell me to do….when I don't do it, it's always
weighing on you,” offered one individual.
3.1.3. Substitution of alternative approaches to conventional
CF management (Table 4)
Substitution of alternative approaches to conventional CF
management was the third theme identified by content analysis.
It was reported by nine (36%) subjects and is composed of onecode, Substitution of Alternatives, which identified alternative
approaches to standard CF care (Table 4). Quotes included, “If
you are staying active and are doing pretty well — if you go
hiking or swimming or to the gym — they consider that pretty
good chest PT [physical therapy],” “The Acapella that I am
supposed to do, I never do that because the saline works like 5
times better than the Acapella ever did. So it's like, why do two
things when one doesn't work half the time?” and “Sometimes I
will go out and run. It is doing the same thing.”
3.1.4. Planned non-adherence (Table 4)
Planned non-adherence was the final theme noted by eight
(32%) subjects. Two codes characterized this theme: Rebellion
Table 4
Additional exemplars characterizing the theme Substitution of alternative approaches to conventional CF management and the theme Intentional non-adherence.
Substitution of alternative approaches to conventional CF management
Code Definition Exemplar quotes Frequency of response n (%)
Substitution
of alternatives
The substitution of an
alternative approach for
standard CF self-management.
• “The 10 or 15 min that you want me to do that I could be
in the gym and I guarantee you, what I am doing in the gym….
is the best medicine that I take.”
9 (36)
• “I am supposed to do the Vest three times a day…I don't
because I go to the gym at night and run.”
• “Riding that bike, in my mind replaces the Vest.”
• “When I am able to run and do things. I almost feel like
that is a substitute.”
Intentional non-adherence
Rebellion Planned non-adherence as
a rebellion against parents'
mandated adherence
• “When you are moving out of the house and everything and get
your independence, you are like ‘Screw this!’ It was pretty much
as soon as I moved out. It (non-adherence) was kind of refreshing; a relief.”
8 (32)
Reward Planned non-adherence as
a reward, or break from
adherence, or as a gift
• “Once a year on my birthday I get a complete day (of non-adherence)
if I am healthy.”
• “Not wanting to let CF run the show all the time…you feel better
when you are not doing your treatments.”
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purposeful rebellion against parents' mandated adherence. It is
characterized by the following quote: “I am away from home
now and I am going to make my own decisions; and I am not
always completely responsible as much as my parents would
like me to be.” The code Reward captured planned non-
adherence as a reward for adherence, as a necessary break from
the monotony of CF self-management, or simply as a gift. “I
skip it once in a great while… [It's] something to look forward
to, just like I look forward to a night out,” offered one subject.
Another said “Knowing you can skip something every once in a
while—that is really fun and really exciting.”
4. Discussion
To our knowledge this is the first qualitative study that
examines the barriers and facilitators of adherence to chronic
CF regimens among older adolescents and adults. As more
individuals with CF enter adulthood and as additional chronic
therapies are added to the regimen, it is increasingly important
to identify factors that impede and facilitate adherence unique to
this segment of the CF population. Four broad themes
contributing to non-adherence emerged from the interview
process: barriers to CF self-management, facilitators of CF self-
management, substitution of alternative approaches to conven-
tional management, and planned non-adherence. While we
identified many of the same barriers and facilitators that have
been found in the pediatric CF population, such as regimen
complexity, forgetting, and lack of a routine, we also found
several that appear unique to adults with CF and likely reflects
the normative changes in social networks and time demands
during adulthood.
To our surprise, the most common facilitator identified by
participants was not day-to-day reminders or having routines for
treatment, but rather the role that the CF clinic played in
encouraging self-management. Improved adherence in theweeks preceding and following a clinic visit (“White-coat
compliance”) has been well-documented in other illnesses. Our
participants' comments supported this finding and offered
possible explanations for this behavior in the CF population.
Most frequently mentioned was the influence of anticipating
and receiving PFT results which motivated participants to be
more adherent. Several participants also highlighted the benefits
of positive interactions with the care team, including receiving
empathy for the challenges of adhering to the regimen and
encouragement to persevere. The high value placed on clinic
visits may reflect a developmental shift from parents initially
receiving the bulk of information during pediatric clinic visits to
the patients directly receiving the support and guidance that
their healthcare providers offer. Previous research has shown
that centers with a higher proportion of patients attending four
or more clinic appointments per year had better lung health [23].
These results suggest that one strategy to improve CF outcomes
among adults may be to encourage frequent clinic attendance
that includes feedback of health information (such as PFT
results), and patient-centered counseling. However, clinicians
should be mindful of the time burden of appointments and tailor
the length of the visit to their patients' circumstances and
preferences to maximize regular attendance.
A second theme that emerged that differs from the pediatric
adherence literature is the influence of social support. Older
adolescents and young adults often have dramatic changes in
their social network, shifting away from the central role of
parents in their day-to-day lives towards more emphasis on
peers and romantic relationships. Several participants spoke of
the important yet distal role parents played in self-management
decisions, but others viewed the separation as an opportunity for
freedom from the regimen. Similarly, some participants
developed relationships that supported and enhanced their
adherence, while others participants found it hard to integrate
treatments into their social and romantic lives and their
adherence suffered. Therefore, clinicians should strive to be
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and, with patient permission, consider including supportive
others in treatment planning.
Outcome expectancies — confidence in the efficacy of a
prescribed treatment — also affected self-management prac-
tices. Patients who perceived a therapy to be positively affecting
their health were more likely to adhere to it. However, many
participants did not perceive any short-term benefit from their
treatments and therefore found adhering to the chronic regimen
to be challenging. This may be reflective of an inadequate
understanding of the purpose of a treatment. Fortunately, data
on the positive association between adherence and better health
outcomes are emerging [9] and may be of value to discuss with
patients as a method to increase an individual's outcome
expectancies. Moreover, care teams should ensure that patients
have appropriate knowledge of the purpose of a therapy to
ensure reasonable treatment expectations.
By far the most significant barrier to adhering to the regimen
is treatment burden. Not only is there the aggravation of setting
up and cleaning the equipment, there is the challenge of fitting
the time-consuming regimen into daily life — school, work,
relationships, and other responsibilities and interests. Establish-
ing routines and having social support can help, but clearly the
regimen interferes with the spontaneity and independence that
characterize late adolescence and early adulthood. Weekends
and socializing (particularly if it includes alcohol consumption)
were regularly pinpointed as triggers for non-adherence. Indeed,
a third of participants reported being intentionally non-adherent
to rebel against having a routine, permit spontaneity, or reward
themselves for high adherence on weekdays.
Taken together, the themes identified in this study may have
direct implications for addressing non-adherence in the clinic
setting. In addition to the recommendation provided above, a
better understanding of the patient's lifestyle, health goals, and
routine may help to address issues of treatment burden. Open-
ended questions that normalize non-adherence, such as, “You
have a very busy life. What parts of your regimen are easy for
you to fit in and what parts are more challenging?” are likely to
offer opportunities to problem-solve barriers collaboratively
rather than queries that produce socially desirable responses
such as ”Any problems with adhering to the regimen?”
Patients sometimes omit, substitute, or combine therapies in an
attempt to reduce treatment burden and these alterations may or
may not affect the treatment's therapeutic value. It is therefore
incumbent upon the CF clinic team to provide guidance on these
regimen modifications beyond stating that the patient should be
100%adherent every day. All patients were able to identify barriers
and facilitators of self-management and while most intellectually
accepted that they should adhere to their regimen there was clear
ambivalence about what that should entail. Therefore, counseling
strategies that help resolve ambivalence, such as motivational
interviewing, may be more effective than approaches that focus
solely on education. Building rapport with patients and creating a
non-judgmental atmosphere is a way to obtain an unbiased
appraisal of patient self-management strategies.
Our study had several limitations, the vast majority of which
are inherent in qualitative studies. For example, we assessed thebarriers and facilitators as reported by patients with CF.
However, this study cannot quantify the extent to which these
factors correspond with actual behavior and people may not be
aware of or unwilling to discuss some factors that influence
their behavior. Furthermore, we enrolled a small number of
subjects from one clinic limiting the generalizability of our
findings. However, relevance, and not generalizability, is the
goal of qualitative research. A limitation of this study not
specific to qualitative research is the risk of self-selection bias,
as individuals had to be reachable by telephone, and had to be
healthy and motivated enough to attend the interview. In
addition, social desirability may also have played a role; that is,
subjects may have answered in a manner to satisfy the
researchers. As there is strong social stigma associated with
non-adherence, actual adherence may have been over-reported.
Despite these limitations qualitative research offers the
opportunity to identify novel information that cannot be
obtained by quantitative methods. Indeed, we uncovered
previously unknown barriers and facilitators of CF self-
management that provide essential new knowledge for
clinicians.
Treatment non-adherence is common in CF. Before effective
counseling interventions can be developed it is critical to
understand the barriers to self-management faced by individuals
with CF. This qualitative study identified several barriers and
facilitators experienced by older adolescents and adults with CF
amenable to clinical intervention. Further quantitative research
is needed to measure the impact these facilitators and barriers
have on actual adherence.Acknowledgement
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